Status:

COMPLETED

Micardis® in Patients With Essential Hypertension

Lead Sponsor:

Boehringer Ingelheim

Conditions:

Hypertension

Eligibility:

All Genders

18+ years

Brief Summary

The aim of this observational study was to supplement the data on efficacy, safety, and tolerability of telmisartan under daily conditions in hospitals

Eligibility Criteria

Inclusion

  • Patients with essential hypertension
  • Minimum age of 18 years

Exclusion

  • Not applicable

Key Trial Info

Start Date :

May 1 1999

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

Estimated Enrollment :

1688 Patients enrolled

Trial Details

Trial ID

NCT02187705

Start Date

May 1 1999

Last Update

July 11 2014

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Micardis® in Patients With Essential Hypertension | DecenTrialz